Standardized cGMP peptide synthesis with HPLC purity exceeding 98.0%, specialized counter-ion control, and comprehensive stability data configured for the Vietnamese pharmaceutical manufacturing sector.
Driven by shifting epidemiological patterns, growing clinical investments in functional GI therapies, and nationwide generic formulation upgrades.
Vietnam's rapid urbanization and nutritional changes have triggered higher incidences of Irritable Bowel Syndrome with Constipation (IBS-C), Chronic Idiopathic Constipation (CIC), ulcerative colitis, and short bowel syndrome. Formulators across industrial clusters in Binh Duong and Bac Ninh are expanding gastrointestinal therapeutic portfolios to address this escalating clinical burden.
The Drug Administration of Vietnam (DAV) is strictly aligning its dossier requirements with the ASEAN Common Technical Dossier (ACTD) and ICH Q7 guidelines. Vietnamese pharmaceutical factories need API partners who furnish audited Certificates of Analysis, verifiable impurity profiles, residual solvent testing, and comprehensive Drug Master File (DMF) technical backing.
Domestic drug enterprises are migrating away from simple small molecules toward complex synthetic peptide APIs. Because local chemical synthesis facilities for peptides remain scarce, Vietnamese generic drug manufacturers rely on accredited international peptide CDMOs capable of consistent kilogram-to-ton level batch reproducibility.
Addressing supply security, structural integrity, and synthetic complexities for global and Vietnamese pharmaceutical supply chains.
Peptides like Linaclotide feature 14 amino acids with three complex intramolecular disulfide bridges. Incorrect folding produces inactive isomers. Thinheal solves this with proprietary orthogonal protection strategies that direct regioselective disulfide linkage with >99% conformational fidelity.
Global pharmaceutical procurement demands tight batch-to-batch consistency. Our large-scale SPPS reactors and industrial preparative HPLC columns ensure uniform crystal size, controlled net peptide content, and standardized acetate/trifluoroacetate balance across every delivery.
Entering the Vietnamese market requires rigorous CMC data. We furnish full documentation packages including stability studies under Zone IVB conditions (30°C/75% RH), degradation pathways, validated analytical methods, and qualified impurity markers.
By operating multi-ton synthesis bases with redundant supply pipelines for raw amino acid resins and coupling reagents, Thinheal eliminates material shortages and ensures stable, long-term procurement pricing for Vietnamese pharmaceutical sponsors.
Pioneering green synthesis, non-invasive oral delivery systems, and gut-brain axis peptide therapeutics for upcoming regulatory pipelines.
Transitioning from traditional DMF and NMP hazardous solvents to bio-derived alternatives (e.g., 2-MeTHF, cyclopentyl methyl ether) and continuous flow solid-phase synthesis, lowering carbon intensity and solvent residues to conform to stringent global environmental standards.
Overcoming gastrointestinal enzymatic breakdown via functional permeation enhancers, lipidization, and enteric micro-encapsulation techniques. Partnering with pharmaceutical labs in Hanoi and Ho Chi Minh City to engineer next-generation oral peptide formulations.
Developing dual/triple agonist candidates targeting GLP-1, GLP-2, GIP, and neuroprotective pathways (such as Selank and related central regulators) that target systemic metabolic and functional bowel disorders simultaneously.
Seamless customs navigation, cold-chain assurance, and direct technical consultations for Vietnamese formulation plants.
Peptide APIs are susceptible to thermal degradation. We employ calibrated active-temperature packaging (-20°C to 2-8°C) with continuous IoT dataloggers routed directly from Hangzhou to Noi Bai (HAN) and Tan Son Nhat (SGN) international airports.
Accelerate your DAV filing approvals with technical dossiers aligned with Vietnamese pharmaceutical submission norms, backed by English and Vietnamese regulatory advisory specialists.
Our Asia regional desk provides direct technical alignment, batch reservation options, and on-site audit availability for Vietnamese pharmaceutical quality control directors.
Review our expanded therapeutic and cosmetic peptide APIs manufactured under strict Quality by Design (QbD) principles for regional export.
Common inquiries regarding impurity profiles, cold-chain customs clearance into Vietnam, and regulatory technical documentation.
Thin